𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Heart rate-lowering and -regulating effects of once-daily sustained-release diltiazem

✍ Scribed by William E. Boden; Muriel Vray; Evelyne Eschwege; Delphine Lauret; Rudy Scheldewaert


Book ID
112065547
Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
706 KB
Volume
24
Category
Article
ISSN
0160-9289

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pharmacokinetic analysis of two new sust
✍ Meir Bialer; Salim Hadad; Gershon Golomb; Shimon Barel; Emil Samara; Omar Abu Sa πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 409 KB πŸ‘ 2 views

The pharmacokinetics of two new sustained-release (SR) products of diltiazem, Dilapress 120 mg tablets and Dilapress 240 mg tablets, was analysed and characterized in three different studies, in comparison to the following diltiazem SR formulations: Cardizem Retard, Cardizem SR, and Cardizem CD. Dil

Efficacy and safety of the 200–300 mg su
✍ B. Trimarco; D. Radzik; E. Neveux; A. Wajman; P. Attali; W. Mieghem; J. Ponsonna πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 371 KB

The aim of this multicentre randomised double blind study was to compare the efficacy and safety of the 200-300 mg sustained release diltiazem formulation administered once daily (200-300 SR) with standard diltiazem (D) given three or four times daily to patients with stable angina. Patients aged 59